Black cohosh (Cimicifuga spp.) for menopausal symptoms

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 10, 2012, Pages

  Leach, Matthew J ^a   Moore, Vivienne ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTAEA RACEMOSA EXTRACT; FLUOXETINE; PLACEBO;

ACTAEA; ACTAEA RACEMOSA; ALTERNATIVE MEDICINE; CINAHL; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG THERAPY; EXPERIMENTAL STUDY; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; MENOPAUSE; NIGHT SWEAT; OSTEOPOROSIS; PATIENT SELECTION; POSTMENOPAUSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RED CLOVER; REVIEW; SEXUALITY; SIDE EFFECT; THERAPY; VAGINA ATROPHY; VASOMOTOR SYSTEM; CLIMACTERIUM; CLOVER; DEHYDRATION; DRUG EFFECT; META ANALYSIS; METHODOLOGY; MIDDLE AGED; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SWEATING; VAGINA DISEASE;

CIMICIFUGA; DEHYDRATION; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; PERIMENOPAUSE; PHYTOTHERAPY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SWEATING; TRIFOLIUM; VAGINAL DISEASES;

EID: 84873028242     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007244.pub2     Document Type: Review

References (53)

1. Amsterdam JD, Yao Y, Mao JJ, Soeller I, Rockwell K, Shults J. Randomised, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause. Journal of Clinical Psychopharmacology 2009;29(5):478-83.
2. Bai W, Henneicke-von Zepelin HH, Wang S, Zheng S, Liu J, Zhang Z, et al. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 2007;58(1):31-41.
3. Bebenek M, Kemmler W, von Stengel S, Engelke K, Kalender WA. Effect of exercise and Cimicifuga racemosa (CR BNO 1055) on bone mineral density, 10-year coronary heart disease risk, and menopausal complaints: the randomized controlled Training and Cimicifuga racemosa Erlangen (TRACE) study. Menopause 2010;17(4):791-800.
4. Carlisle A, Jessup JV. Effect of black cohosh on biochemical markers of bone remodeling in postmenopausal women. Dissertation, University of Florida, USA, 2008.
5. Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer CH, Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005;51(4):397-404.
6. Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause 2009;16(6):1156-66.
7. Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. Journal of Clinical Oncology 2001;19(10):2739-45.
8. Kronenberg F, Warren M, Coleton M, Jin Z, McMahon DJ, Sauberli W. Effect of black cohosh extract on hot flashes and other menopausal symptoms. Poster presentation, 20th Annual Meeting, North American Menopause Society, San Diego, CA 2009.
9. Lehmann-Willenbrock WE, Riedel HH. Clinical and endocrinologic examinations about therapy of climacteric symptoms following hysterectomy with remaining ovaries [Klinische und endokronologische untersuchungen zur therapie ovarieller ausfallserscheinungen nach hysterektomie unter belassung der adnexe]. Zentralblatt für Gynäkologie 1988;110(10):611-8.
10. Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecological Endocrinology 2005;20(1):30-5.
11. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Annals of Internal Medicine 2006;145(12):869-79.
12. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 2008;15(1):51-8.
13. Oktem M, Eroglu D, Karahan HB, Taskintuna N, Kuscu E, Zeyneloglu HB. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Advances in Therapy 2007;24(2):448-61.
14. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von, et al. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstetrics & Gynecology 2005;105(5):1074-83.
15. Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. Journal of Clinical Oncology 2006;24(18):2836-41.
16. Stoll W. Phytopharmacon influences atrophic vaginal epithelium: double blind study: cimicifuga vs. estrogenic substances [Phytotherapeutikum beeinfluBt atrophisches vaginalepithel: doppelblindversuch cimicifuga vs. ostrogenpraparat]. Therapeutikum 1987;1:23-31.
17. Wuttke W, Gorkow C, Seidlová-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause 2006a;13(2):185-96.
18. Wuttke W, Raus K, Gorkow C. Efficacy and tolerability of the Black cohosh (Actaea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogens-controlled study. Maturitas 2006b;55(Suppl 1):S83-91.
19. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44(Suppl 1):S67-77.
20. Blohmer JU, Graubaum HJ, Busch R, Grunwald J, Wernecke KD, Uebelhack R. Cimicifuga and Hypericum as a fixed combination against climacteric complaints. A randomised controlled trial. Zeitschrift fur Phytotherapie 2007;28(2):67-70.
21. Chung DJ, Kim HY, Park KH, Jeong KA, Lee SK, Le YI, et al. Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptoms. Yonsei Medical Journal 2007;48(2):289-94.
22. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizome): a 6-month clinical study demonstrates no systemic estrogenic effect. Journal of Women's Health & Gender-Based Medicine 2002;11(2):163-74.
23. Myoung-Suk N, Young-Lim O, Heung-Yeol K, Wan-Kyo E, Hong-Bae K. The effects of black cohosh root extract on the vasomotor symptom and bone metabolism of postmenopausal women. Korean Journal of Bone Metabolism 2008;15(2):155-62.
24. Park HM, Kim JG, Yoon BK, Lee BI, Choi H, Seo SH. The effect of black cohosh with St. John's wort (Feramin-Q) on climacteric symptoms: multicenter randomised double-blind placebo-controlled trial. Korean Journal of Obstetrics & Gynecology 2006;48(10):2403-13.
25. Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomised, controlled, double-blind pilot study. Gynecological Endocrinology 2007;23(2):117-22.
26. Sammartino A, Tommaselli GA, Gargano V, di Carlo C, Attianese W, Nappi C. Short term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomised, placebo-controlled trial. Gynecological Endocrinology 2006;22(11):646-50.
27. Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD. Black cohosh and St. John's wort for climacteric complaints: a randomised trial. Obstetrics & Gynecology 2006;107(2 Pt 1):247-55.
28. Verhoeven MO, van der Mooren MJ, van de Weijer PH, Verdegem PJ, van der Burgt LM, Kenemans P. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomised, placebo-controlled, double-blind study. Menopause 2005;12(4):412-20.
29. Aly M. Use of black cohosh (Cimicifuga racemosa) in postmenopausal women: a randomized controlled study. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S646.
30. Kim HY, Choi H, Park HM, Lee BS, Kang BM, Yoon BK, et al. The effects of black cohosh root extract on the vasomotor symptom and bone metabolism of menopausal women. Maturitas 2009;63(Suppl 1):S75.
31. Black Cohosh Extract for the Management of Moderate to Severe Menopausal Symptoms in Thai Women. Ongoing study December 2011.
32. Australian Drug Evaluation Committee (ADEC). ADEC Summary Statement on HRT. Canberra: Therapeutic Goods Administration, 2004.
33. Blumel JE, Castelo-Branco C, Binfa L, Gramegna G, Tacla X, Aracena B, et al. Quality of life after the menopause: a population study. Maturitas 2000;34(1):17-23.
34. Blumenthal M. The ABC Clinical Guide to Herbs. Austin: American Botanical Council, 2003.
35. Borrelli F, Izzo AA, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sciences 2003;73(10):1215-29.
36. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacological Research 2008;58(1):8-14.
37. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. American Journal of Obstetrics & Gynecology 2008;199(5):455-66.
38. Corwin EJ. Handbook of Pathophysiology. Philadelphia: Lippincott, Williams & Wilkins, 2008.
39. Dog TL. Menopause: a review of botanical dietary supplements. The American Journal of Medicine 2005;118(Suppl 2):98S-108S.
40. Farquhar CM, Marjoribanks J, Lethaby A, Lamberts Q, Suckling JA, Cochrane HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004143.pub3]
41. Gabriel-Sánchez R, Carmona L, Roque M, Sánchez-Gómez LM, Bonfill X. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD002229.pub2]
42. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
43. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
44. Keville K. The Illustrated Herb Encyclopedia. East Roseville: Simon & Shuster Australia, 1991.
45. MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD002978.pub2]
46. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. American Journal of Human Biology 1992;4(1):37-46.
47. Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Edinburgh: Churchill Livingstone, 2000.
48. Mishra G, Kuh D. Perceived change in quality of life during the menopause. Social Science & Medicine 2006;62(1):93-102.
49. Peeyananjarassri K, Baber R. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric 2005;8(1):13-23.
50. Porter RS, Kaplan JL. The Merck Manual Online. Whitehouse Station, New Jersey: Merck Research Laboratories, 2011.
51. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
52. Roberts H. Safety of herbal medicinal products in women with breast cancer. Maturitas 2010;66(4):363-369.
53. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Journal of the American Medical Association 2002;288(3):321-33.